China Resource Double-crane Pharmaceutical CO., Ltd

About China Resource Double-crane Pharmaceutical CO., Ltd

Five production bases,GMP-Certified Manufacturer of APIs,With FDA, CEP, WHO etc

China Resource Double-Crane Pharmaceutical Co., Ltd API Division has 5 production bases in total. At present, it has about 1300 employees, of which 200 is for R&D. It covers an area of about 600,000 square meters, has more than 50 products, has sales and registrations in more than 30 countries and re...

  • CN
  • 2022
    On CPHI since
  • 5
    Certificates
  • 5000+
    Employees
Company types
Generics/Biosimilars Manufacturer
Primary activities
API Producer
Contact info

Products from China Resource Double-crane Pharmaceutical CO., Ltd (3)

  • Pregabalin

    Product Pregabalin

    Pregabalin is one of our mature products, with an annual production capacity of 5t/year. Shangqiu Double Crane Ltd. is an important API production base of CR Double Crane Drug Substance Business Division. Its business scope is the production, processing, sales, research and development of APIs and pharm...
  • Allopurinol

    Product Allopurinol

    Allopurinol is one of our mature products. With the strong strength of CR Double-Crane Pharmaceutical Co., Ltd., our company keeps improving and optimizing the production, R&D, technology and equipment to ensure the product quality fully meets the requirements at home and abroad. To ensure the quali...
  • Isoniazid

    Product Isoniazid

    Isoniazid is one of our mature products, with an annual production capacity of 350mt/year. With the strong strength of China Resources Double-Crane Pharmaceutical Co., Ltd., our company has continuously improved and optimized production, R & D, technology and equipments to ensure that the product q...

China Resource Double-crane Pharmaceutical CO., Ltd Resources (1)

  • Brochure Company introduction

    Five production bases,GMP-Certified Manufacturer of APIs,With FDA, CEP, WHO etc

    China Resource Double-Crane Pharmaceutical Co., Ltd API Division has 5 production bases in total. At present, it has about 1300 employees, of which 200 is for R&D. It covers an area of about 600,000 square meters, has more than 50 products, has sales and registrations in more than 30 countries and regions, and has a relatively complete API research, production and marketing integration capability. 

    Strong products: Varsaltan,Allopurinol,Isoniazid, Pregabalin,Nicotinamide, Bendazole Hydrochloride, Amlodipine Besylate,Terazosin HCL, Sulfamethazine,

    Olmesartan Medoxomil,Azilsartan,Pitavastatin Calcium, Sodium Nitroprusside,Triamterenum.